Skip to main content

ETH269 8 mg (Doxazosin Mesylate 8 mg)

Pill with imprint ETH269 8 mg is Blue, Elliptical/Oval and has been identified as Doxazosin Mesylate 8 mg. It is supplied by Ethex Corporation.

Doxazosin is used in the treatment of raynaud's syndrome; benign prostatic hyperplasia; high blood pressure and belongs to the drug classes alpha-adrenoreceptor antagonists, antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ETH269 8 mg

Doxazosin Mesylate

ETH269 8 mg
8 mg
12.00 mm
Prescription only
Drug Class
Alpha-adrenoreceptor antagonists, Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ethex Corporation
National Drug Code (NDC)
58177-0269 (Discontinued)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.